Intra-Abdominal and Abdominal Wall Desmoid Fibromatosis.

Item

http://www.wikidata.org/entity/Q55052699

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Intra-Abdominal and Abdominal Wall Desmoid Fibromatosis.

@en

Intra-Abdominal and Abdominal Wall Desmoid Fibromatosis.

@nl

type

Item

label

Intra-Abdominal and Abdominal Wall Desmoid Fibromatosis.

@en

Intra-Abdominal and Abdominal Wall Desmoid Fibromatosis.

@nl

prefLabel

Intra-Abdominal and Abdominal Wall Desmoid Fibromatosis.

@en

Intra-Abdominal and Abdominal Wall Desmoid Fibromatosis.

@nl

P1476

Intra-Abdominal and Abdominal Wall Desmoid Fibromatosis

@en

P2093

Raphael E Pollock

http://www.w3.org/2001/XMLSchema#string

P2860

Activity of Sorafenib against desmoid tumor/deep fibromatosis

Surgical resection for non-familial adenomatous polyposis-related intra-abdominal fibromatosis

High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management.

Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles.

A prognostic nomogram for prediction of recurrence in desmoid fibromatosis.

Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review.

Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up.

Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial.

Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation.

Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group.

P2888

s40487-016-0017-z

P304

57-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40487-016-0017-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

J Harrison Howard

P577

2016-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

293193800

http://www.w3.org/2001/XMLSchema#string

P6179

1020732302

http://www.w3.org/2001/XMLSchema#string

P698

28261640

http://www.w3.org/2001/XMLSchema#string

P932

5315078

http://www.w3.org/2001/XMLSchema#string